Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX) ; volume:17 ; number:1 ; day:28 ; month:4 ; year:2016 ; pages:1-10 ; date:12.2016
BMC pharmacology & toxicology ; 17, Heft 1 (28.4.2016), 1-10, 12.2016
- Keyword
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Creator
-
Kunøe, Nikolaj
- Contributor
-
Opheim, Arild
Solli, Kristin Klemmetsby
Gaulen, Zhanna
Sharma-Haase, Kamni
Latif, Zill-e-Huma
Tanum, Lars
SpringerLink (Online service)
- DOI
-
10.1186/s40360-016-0061-1
- URN
-
urn:nbn:de:1111-201703167389
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kunøe, Nikolaj
- Opheim, Arild
- Solli, Kristin Klemmetsby
- Gaulen, Zhanna
- Sharma-Haase, Kamni
- Latif, Zill-e-Huma
- Tanum, Lars
- SpringerLink (Online service)
Other Objects (12)
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial
Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial
Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial